161 related articles for article (PubMed ID: 27346426)
1. Timing of anticoagulation therapy in patients with acute ischaemic stroke and atrial fibrillation.
Paciaroni M; Agnelli G; Ageno W; Caso V
Thromb Haemost; 2016 Aug; 116(3):410-6. PubMed ID: 27346426
[TBL] [Abstract][Full Text] [Related]
2. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.
Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J
Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413
[TBL] [Abstract][Full Text] [Related]
3. Timing of Initiation of Oral Anticoagulation after Acute Ischemic Stroke in Patients with Atrial Fibrillation.
Smythe MA; Parker D; Garwood CL; Cuker A; Messé SR
Pharmacotherapy; 2020 Jan; 40(1):55-71. PubMed ID: 31698510
[TBL] [Abstract][Full Text] [Related]
4. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
[TBL] [Abstract][Full Text] [Related]
5. Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study.
Yasaka M; Minematsu K; Toyoda K; Yamagami H; Yoshimura S; Nagao T; Mori E; Hirano T; Hamasaki T; Yamaguchi T
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1342-8. PubMed ID: 26987488
[TBL] [Abstract][Full Text] [Related]
6. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
7. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants.
Hankey GJ
Thromb Haemost; 2014 May; 111(5):808-16. PubMed ID: 24285341
[TBL] [Abstract][Full Text] [Related]
8. Timing of Anticoagulation after Stroke in Patients with Non-Valvular Atrial Fibrillation Assessment of Provider Practices.
Osteraas ND; Sagalovich M; Glover JJ; Dafer RM
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106014. PubMed ID: 34364012
[TBL] [Abstract][Full Text] [Related]
9. Early anticoagulation in atrial fibrillation-related acute ischaemic stroke: efficacy and safety profile.
Matos-Ribeiro J; Castro-Chaves P; Oliveira-Ferreira M; Fonseca L; Pintalhao M
J Neurol; 2022 Apr; 269(4):2099-2112. PubMed ID: 34499205
[TBL] [Abstract][Full Text] [Related]
10. Novel oral anticoagulants for the prevention of thromboembolism in patients with atrial fibrillation.
Lang NN; Connelly DT
J R Coll Physicians Edinb; 2013; 43(2):151-8. PubMed ID: 23734359
[TBL] [Abstract][Full Text] [Related]
11. [Atrial fibrillation and stroke].
Mattle HP; Schwerzmann M; Seiler Ch
Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
Gomberg-Maitland M; Wenger NK; Feyzi J; Lengyel M; Volgman AS; Petersen P; Frison L; Halperin JL
Eur Heart J; 2006 Aug; 27(16):1947-53. PubMed ID: 16774980
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants in non-valvular atrial fibrillation.
Potpara TS; Lip GY
Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
[TBL] [Abstract][Full Text] [Related]
14. Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.
Charidimou A; Boulouis G; Shams S; Calvet D; Shoamanesh A;
J Neurol Sci; 2017 Jul; 378():102-109. PubMed ID: 28566143
[TBL] [Abstract][Full Text] [Related]
15. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
[TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
Potpara TS; Lip GY
Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
[TBL] [Abstract][Full Text] [Related]
17. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
18. [Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].
Di Lullo L; Barbera V; Bellasi A; Cozzolino M; Russo D; Otranto G; Santoboni F; Ronco C
G Ital Nefrol; 2017 Apr; 34(2):58-73. PubMed ID: 28682563
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
20. Safely Addressing Patients with Atrial Fibrillation to Early Anticoagulation after Acute Stroke.
Canavero I; Cavallini A; Sacchi L; Quaglini S; Arnò N; Perrone P; DeLodovici ML; Marcheselli S; Micieli G
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):7-18. PubMed ID: 27614403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
